We demonstrate that flow cytometry of early untreated NSCLC patients shows an upregulation of CD39 expression in the tumor tissue among natural killer (NK) cells, fibroblasts and T cells. This evidence concerns the gene ENTPD1 and non-small cell lung carcinoma.